- Home
- OMCL vs REVG Comparison
OMCL vs REVG Comparison
Compare OMCL & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- REVG
- Stock Information
- Founded
- OMCL 1992
- REVG 2008
- Country
- OMCL United States
- REVG United States
- Employees
- OMCL N/A
- REVG N/A
- Industry
- OMCL Computer Manufacturing
- REVG Auto Manufacturing
- Sector
- OMCL Technology
- REVG Consumer Discretionary
- Exchange
- OMCL Nasdaq
- REVG Nasdaq
- Market Cap
- OMCL 1.5B
- REVG N/A
- IPO Year
- OMCL 2001
- REVG 2017
- Fundamental
- Price
- OMCL $25.39
- REVG $35.80
- Analyst Decision
- OMCL Buy
- REVG Hold
- Analyst Count
- OMCL 6
- REVG 4
- Target Price
- OMCL $45.83
- REVG $33.75
- AVG Volume (30 Days)
- OMCL 727.0K
- REVG 619.5K
- Earning Date
- OMCL 05-06-2025
- REVG 06-04-2025
- Dividend Yield
- OMCL N/A
- REVG 0.68%
- EPS Growth
- OMCL N/A
- REVG N/A
- EPS
- OMCL 0.45
- REVG 1.77
- Revenue
- OMCL $1,135,755,000.00
- REVG $2,319,300,000.00
- Revenue This Year
- OMCL $3.75
- REVG $1.97
- Revenue Next Year
- OMCL $4.42
- REVG $6.51
- P/E Ratio
- OMCL $56.43
- REVG $20.12
- Revenue Growth
- OMCL 3.00
- REVG N/A
- 52 Week Low
- OMCL $22.66
- REVG $21.54
- 52 Week High
- OMCL $55.75
- REVG $36.06
- Technical
- Relative Strength Index (RSI)
- OMCL 26.13
- REVG 69.04
- Support Level
- OMCL $22.66
- REVG $31.57
- Resistance Level
- OMCL $32.18
- REVG $36.06
- Average True Range (ATR)
- OMCL 1.18
- REVG 1.06
- MACD
- OMCL -0.46
- REVG 0.48
- Stochastic Oscillator
- OMCL 28.68
- REVG 96.57
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.